Benefit of Repetitive Intrathecal Triamcinolone Acetonide Therapy in Predominantly Spinal Multiple Sclerosis: Prediction By Upper Spinal Cord Atrophy

Intrathecal injection of triamcinolone acetonide (TCA) has been shown to provide substantial benefit in a subset of progressive multiple sclerosis (MS) patients with predominant spinal symptoms. We examined whether atrophy of the upper spinal cord (USC) as measured by MRI can serve as a predictive m...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lukas, Carsten, Bellenberg, Barbara, Hahn, Horst K., Rexilius, Jan, Drescher, Robert, Hellwig, Kerstin, Köster, Odo, Schimrigk, Sebastian
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2009
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3002603/
https://ncbi.nlm.nih.gov/pubmed/21180629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285609343480
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items